in CHCl3); found: C, 49.3; H, 4.7. Calc. for C6H7O3F: C, 49.3; H,
20 min and the stirring continued for 48 h at rt. TLC in S2 indicated
absence of the starting 28. The reaction mixture was worked-up as
described in general procedure for reaction with DAST except that
water was used instead of 1% aqueous HCl. Chromatography in
S3 afforded first crystalline 1,6-anhydro-2,3-di-O-benzylidene-4-
deoxy-4-fluoro-b-D-talopyranose (29, 89 mg) which contained 9%
of an unknown fluorine-containing product according to NMR.
Recrystallization from ethanol gave pure 29 (53 mg, 32%), mp
4.8%; m/z (EI) 99 (100%), 59 (18), 72 (15), 75 (12), 146 (M+, 0.1).
Reaction of 1,6:2,3-dianhydro-b-D-gulopyranose (4)
The reaction was carried out using 4 (200 mg, 1.39 mmol) and
DAST (0.6 mL, 4.54 mmol). Chromatography in ethyl acetate -
light petroleum 1 : 7 afforded 1,6:2,3-dianhydro-4-deoxy-4- fluoro-
b-D-gulopyranose (23, 125 mg, 61%); mp 73–75 ◦C (from ethanol);
[a]2D5 +42 (c 0.1 in CHCl3); found: C, 49.4; H, 4.8. Calc. for
C6H7O3F: C, 49.3; H, 4.8%; m/z (EI) 99 (100%), 59 (19), 72 (14),
75 (11), 146 (M+, 0.2). Further elution gave first a mixture of 23
and 24 (29 mg, 15%) in ratio 1 : 17 by GC-MS, then syrupy 1,6:2,3-
dianhydro-5-deoxy-5-fluoro-a-L-talofuranose (24) (52 mg, 26%),
found: C, 49.5; H, 4.9. Calc. for C6H7O3F: C, 49.3; H, 4.8%; m/z
(EI) 88 (100%), 71 (46), 59 (45), 99 (27), 146 (M+, 0.4).
◦
109–112 C, [a]2D5 -56 (c 0.20 in CHCl3); found: C, 61.8; H, 5.2.
Calc. for C13H13O4F: C, 61.9; H, 5.2%. Further elution afforded
the unreacted 28 (9 mg, 5%).
Reaction of 31 with DAST. A solution of 31 (200 mg,
0.72 mmol) in dichloromethane (1.5 mL) was added to a solution
of DAST (0.35 mL, 2.65 mmol) in dichloromethane (2.0 mL)
under cooling (–50 ◦C) and stirring. The cooling bath was removed
after 20 min and the stirring continued for 24 h at rt. TLC in
S2 indicated absence of the starting 31. The reaction mixture
was worked-up as described in general procedure for reaction
with DAST. Chromatography in. S4 afforded first syrupy 2,6-
anhydro-3-azido-3-deoxy-4-O-benzyl-a-D-talopyranosyl fluoride
(32, 69 mg, 34%), [a]2D5 -135 (c 0.44 in CHCl3); found: C, 56.05; H,
5.1; N, 14.7. Calc. for C13H14O3N3: C, 55.9; H, 5.05; N, 15.05%.
Further elution afforded syrupy 2,6-anhydro-3-azido-3-deoxy-4-
O-benzyl-b-D-talopyranosyl fluoride (33, 92 mg, 46%), [a]2D5 -108
(c 0.27 in CHCl3); found: C, 56.2; H, 5.1; N, 14.5. Calc. for
C13H14O3N3: C, 55.9; H, 5.05; N, 15.05%.
Reaction of 1,6:2,3-dianhydro-b-D-mannopyranose (3)
The reaction was carried out using 3 (200 mg, 1.39 mmol)
and DAST (0.6 mL, 4.54 mmol). Chromatography in S3 gave
first an inseparable mixture of 1,6:2,3-dianhydro-4-deoxy-4-
fluoro-b-D-talopyranose and 1,6:2,3-dianhydro-4-deoxy-4-fluoro-
b-D-mannopyranose (22 and 25, 107 mg, 52%), the ratio of 22 and
1
25 was 21 : 4 according to H NMR, the NMR spectrum of the
major product 22 was identical with that of the product prepared
from 8. The epimers 22 and 25 were also inseparable by GC-
MS. Further elution gave 1,6:2,4-dianhydro-3-deoxy-3-fluoro-b-
D-idopyranose (26, 24 mg, 12%) contaminated with impurities
(GC-MS), recrystallization fromethylacetate-light petroleum gave
pure 26 (19 mg, 9%) mp 110 ◦C, found: C, 49.4; H, 4.85. Calc. for
C6H7O3F: C, 49.3; H, 4.8%; m/z (EI) 72 (100%), 59 (75), 116 (15),
40 (6).
Acknowledgements
The service of the X-ray diffractometer was supported by the
Ministry of Education (Grant Nos. MSM0021620857. NMR
measurements were supported by the Grant Agency of ASCR,
Grant No. IAA400720706.
Reaction of 1,6:2,3-dianhydro-b-D-allopyranose (12)
Notes and references
The reaction was carried out using 12 (200 mg, 1.39 mmol)
and DAST (0.6 mL, 4.54 mmol). Chromatography in
S3 gave (5R)-1,41:2,3-dianhydro-4-deoxy-4-C-hydroxymethyl-D-
lyxo-pentodialdo-1,5-pyranosid-5-yl fluoride (27, 34 mg, 17%),
mp 83–92 ◦C, found: C, 49.3; H, 4.8. Calc. for C6H7O3F: C, 49.3;
H, 4.8%; m/z (EI) 69 (100%), 87 (46), 100 (42), 115 (3). Further
elution gave the starting dianhydro derivative 12 (10 mg, 5%).
1 (a) T. Tsuchiya, Chemistry and Developments of Fluorinated Carbo-
hydrates, in Advances in Carbohydrate Chemistry and Biochemistry, vol.
48, ed., D. Horton, Academic Press, 1990, p 91–277; (b) K. Dax, M.
Albert, J. Ortner and B. J. Paul, Curr. Org. Chem., 1999, 3, 287–307;
(c) K. Dax, M. Albert, J. Ortner and B. J. Paul, Carbohydr. Res., 2000,
327, 47–86; (d) A. A. E. Penglis, Adv. Carbohydr. Chem. Biochem., 1981,
38, 195–285; (e) Y. Cheng, A. L. Guo and D. S. Guo, Curr. Org. Chem.,
2010, 14, 977–999; (f) P. J. Card, J. Carbohydr. Chem., 1985, 4, 451–487.
2 (a) I. P. Street, C. R. Armstrong and S. G. Withers, Biochemistry, 1986,
25, 6021–6027; (b) R. Miethchen, J. Fluorine Chem., 2004, 125, 895–
901.
3 (a) D. O’Hagan, C. Bilton, J. A. K. Howard, L. Knight and D. J. Tozer,
J. Chem. Soc., Perkin Trans. 2, 2000, 605–607; (b) M. P. Freitas and
R. Rittner, THEOCHEM, 2007, 807, 159–162; (c) D. O’Hagan, Chem.
Soc. Rev., 2008, 37, 308–319; (d) W. K. Hagmann, J. Med. Chem., 2008,
51, 4359–4369; (e) L. Hunter, Beilstein J. Org. Chem., 2010, 6, 38; (f) M.
G. Saulnier, B. N. Balasubramanian, B. H. Long, D. B. Frennesson, E.
Ruediger, K. Zimmermann, J. T. Eummer, D. R. St. Laurent, K. M.
Stoffan, B. N. Naidu, M. Mahler, F. Beaulieu, C. Bachand, F. Y. Lee,
C. R. Fairchild, L. K. Stadnick, W. C. Rose, C. Solomon, H. Wong,
A. Martel, J. J. Wright, R. Kramer, D. R. Langley and D. M. Vyas, J.
Med. Chem., 2005, 48, 2258–2261; (g) H. Ferret, I. Dechamps, D. G.
Pardo, L. Van Hijfte and J. Cossy, Arkivoc, 2010, viii, 126–159.
4 (a) N. C. Srivastav, N. Shakya, M. Mak, B. Agrawal, D. L. Tyrrell
and R. Kumar, J. Med. Chem., 2010, 53, 7156–7166; (b) X. Jiang, J.
Li, R. Zhang, Y. Zhu and J. Shen, Org. Process Res. Dev., 2008, 12,
888–891; (c) J. J. Fox, K. A. Watanabe, T. C. Chou, R. F. Schinazi,
K. F. Soike, I. Fourel, G. Hantz and C. Trepo, Antiviral Activities
of 2¢-Fluorinated Arabinosyl-Pyrimidine Nucleosides In Fluorinated
Reaction of 37 with DAST. The reaction was carried out using
37 (150 mg, 0.44 mmol) and DAST (0.5 mL, 3.78 mmol). Chro-
matography in ethyl acetate-light petroleum 1 : 7 afforded 116 mg
(77%) of a mixture of 1,6-anhydro-3-azido-2,3-dideoxy-2-fluoro-
4-O-tosyl-b-D-glucopyranose (38) and 2,5-dianhydro-3-azido-3-
deoxy-4-O-tosyl-a-D-altroseptanosyl fluoride (39). The ratio of 38
and 39 was estimated to be 6 : 1 (NMR). Semipreparative reverse
phase HPLC of a sample of the mixture (7 mg) in acetonitrile-water
1 : 1 afforded pure syrupy 38 (4 mg), nmax(film)/cm-1 2098(N3),
HREIMS: m/z 366.05295 calcd. for C13H14O5FN3SNa: 366.05304.
Compound 39 was obtained only as an enriched HPLC fraction
(in cca 73% purity)
Reaction of 28 with DAST. A solution of 2817 (166 mg,
0.66 mmol) in dichloromethane (2.0 mL) was added to a solution
of DAST (0.35 mL, 2.65 mmol) in dichloromethane (2.0 mL) under
cooling (-50 ◦C) and stirring. The cooling bath was removed after
402 | Org. Biomol. Chem., 2012, 10, 394–403
This journal is
The Royal Society of Chemistry 2012
©